Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ALOGLIPTIN AND PIOGLITAZONE TABLETS safely and effectively. See full prescribing information for ALOGLIPTIN AND PIOGLITAZONE TABLETS. Alogliptin and Pioglitazone Tablets, for oral use Initial U.S. Approval: 2013
Medication labelWhy this: Advisory · dailymed-prescription
Alogliptin and pioglitazone tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use Alogliptin and pioglitazone tablets are not recommended for use in patients with type 1 diabetes mellitus.
- generic_name
- alogliptin benzoate and pioglitazone hydrochloride
- product_names
- Alogliptin Benzoate and Pioglitazone hydrochloride
- ndc
- 45802-260, 45802-260-65, 45802-351, 45802-351-65, 45802-499, 45802-499-65, 45802-402, 45802-402-65
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en